APAC

The hospital developed a multidisciplinary programme supporting cancer patients through clinical treatment, traditional medicine, rehabilitation, and sustained community engagement.

The company received national recognition for its culture-building programmes and large-scale community health screenings.

The hospital reduced fall incidents in its General Nursing Unit through a structured quality improvement programme focused on education, risk assessment, and staff training.

The group was recognised for its screening service focused on infectious genetic remnants linked to erectile dysfunction.

The centre was recognised for addressing long queues, crowded hospital environments, and limited personalised care.

The hospital built a culture-driven hand hygiene programme that strengthened infection prevention.

The initiative strengthened access to advanced retinopathy of prematurity treatment and helped reduce long-term costs.

The hospital advances clinical innovation and empowers its people to lead meaningful change.

The organisation was honoured for implementing a provider-led corporate health programme.

Its initiative ensures that coordinated emergency care and multidisciplinary follow-up support patient recovery.

The hospital was recognised for its triple ISO certifications, 4-Star Green and Safe Health Facilities rating, and strengthened emergency preparedness systems.

The hospital earned the accolade for expanding neuromodulation therapies and rehabilitation services.

It won for embedding structured ESG governance, certified safety standards, and integrated systems across its operations.

The awards programmes recognise top-notch healthcare providers, pharmaceutical companies, and health tech pioneers for transforming care delivery across Asia.

Patients want healthcare that is "fast to cook, good to eat, and cheap."

China accounted for nearly 32% of APAC’s next-generation sequencers market in 2025.